Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
1.0%
0.57
1.00
—
—
-35.1%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
— months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
3,080
-33.4%
7.2%
22.4%
14%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
UTI - Credit Risk Fund.
Regular Plan · Growth
Allocation
By asset
By market cap
Concentration
Number of stocks
1
Top 5 stocks
—
Top 10 stocks
—
Top 20 stocks
—
Lines in the filing
1
Largest holding
—
Largest sector
ICRA-D —
Effective stocks
—
Sectors held
1
Cash
0.00%
Effective stocks is what the concentration works out to: a fund holding
1 names but most of its money in a few
behaves like a fund of —. Cash includes repo and TREPS, which
every fund parks money in overnight.
UTI - Credit Risk Fund.
Regular Plan · Growth · holdings
UTI - Credit Risk Fund.
Regular Plan · Growth · where the money sits
A ₹10,000 monthly SIP over five years
Invested
Value
Gain
XIRR
₹600,000
₹714,298
₹114,298
6.92%
XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has
been invested for a different length of time.
Not investment advice. InvestVerdict is not a SEBI-registered Investment
Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 1 Nov 2026.
